{"gene":"AP3D1","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":2016,"finding":"AP3D1 encodes the AP3δ subunit essential for both the ubiquitous and neuronal forms of the AP-3 complex; homozygous loss-of-function mutation in AP3D1 destabilizes the entire AP-3 complex, and retroviral reconstitution with wild-type AP3D1 restores AP-3 complex formation and rescues the T-cell degranulation defect in patient cells.","method":"Patient genetics (whole exome sequencing), retroviral reconstitution assay, functional degranulation assay in T cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — retroviral reconstitution with functional rescue (degranulation assay) plus patient genetics; replicated by independent clinical report (PMID:30472485)","pmids":["26744459"],"is_preprint":false},{"year":2018,"finding":"Homozygous frameshift mutation in AP3D1 (c.1978delG, p.Ala660Argfs*54) causes loss of AP-3 complex function, leading to abnormal platelet storage pathway, confirming AP3D1/AP3δ is required for lysosome-related organelle biogenesis including platelet dense granules.","method":"Whole exome sequencing, platelet storage pathway analysis","journal":"European journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — independent replication of AP3D1 loss-of-function with functional platelet assay, single lab","pmids":["30472485"],"is_preprint":false},{"year":2021,"finding":"AP3D1 binds palmitoylated IFNGR1 (S-palmitoylated on Cys122) and sorts it to the lysosome for degradation; optineurin interacts with AP3D1 to prevent this palmitoylation-dependent lysosomal sorting, thereby maintaining IFNGR1 surface expression and IFNγ/MHC-I signaling.","method":"Co-immunoprecipitation, palmitoylation assay, lysosomal trafficking assay, genetic loss-of-function (optineurin KO), rescue experiments","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, palmitoylation mapping (Cys122), lysosomal sorting assay, and in vivo rescue across multiple orthogonal methods in one study","pmids":["33627378"],"is_preprint":false},{"year":2021,"finding":"AP3D1 forms a cellular protein complex with FAM13A and TGFβ2; this complex mediates secretion of TGFβ2 through an AP-3-dependent pathway involving delivery to late endosomal compartments for exosomal secretion, with FAM13A acting as a negative regulator targeting a late stage of coat-cargo dissociation.","method":"Co-immunoprecipitation, functional secretion assay, protein-protein interaction network validation","journal":"American journal of respiratory cell and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP demonstrating ternary complex plus functional secretion assay, single lab","pmids":["34166600"],"is_preprint":false},{"year":2021,"finding":"Knockdown of AP3D1 (AP-3 complex subunit) alters the lysosomal localization of wild-type RNF13 and causes abnormal enlargement of endosomal vesicles, placing AP3D1 upstream of RNF13 endolysosomal trafficking.","method":"siRNA knockdown of AP3D1, fluorescence microscopy co-localization with LAMP1, endosomal vesicle size measurement","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function knockdown with defined cellular phenotype (endosomal size, lysosomal mislocalization), single lab, two orthogonal readouts","pmids":["34831286"],"is_preprint":false},{"year":2009,"finding":"Loss of Ap3d1 in mocha mice (10,639 bp deletion covering exons 2–6) results in deficiency in vesicle transport and storage, affecting neurotransmitter vesicle turnover; Ap3d1-null hippocampal neurons show higher input resistance and faster, stronger depression of glutamatergic autaptic EPSCs compared to controls.","method":"Genomic sequencing to map deletion, patch-clamp electrophysiology on cultured hippocampal neurons from Ap3d1-/- mice","journal":"BMC research notes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined genetic null model with functional electrophysiological readout in neurons, single lab","pmids":["19032734"],"is_preprint":false},{"year":2009,"finding":"Ap3d1 loss in mocha mice causes complete absence of cholinergic amacrine cells and reduction of parvalbumin-expressing and other amacrine cell subtypes in the retina without affecting overall retinal layering, cell number, proliferation, or apoptosis, indicating AP3D1 regulates retinal progenitor cell competence and differentiation.","method":"Immunohistochemistry and morphological analysis of Ap3d1-/- (mocha) mouse retina at birth","journal":"International journal of developmental neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined genetic null with specific cellular phenotype (amacrine cell subtypes), single lab","pmids":["19631730"],"is_preprint":false},{"year":2009,"finding":"The Nxf1(CAST) allele suppresses the Ap3d1(mh2J) IAP retrovirus insertion mutation by approximately 2-fold increase in correctly-spliced Ap3d1 mRNA and decrease in mutant-specific alternatively-processed RNA, demonstrating that Ap3d1 expression can be rescued at a functional threshold through modulation of pre-mRNA splicing.","method":"Genetic epistasis (suppressor screen with Nxf1 allele), quantitative RT-PCR for splice isoforms in mocha mice","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic suppressor with molecular splice quantification, single lab but orthogonal genetic and molecular methods","pmids":["19436707"],"is_preprint":false},{"year":2022,"finding":"Loss of ap3d1 in zebrafish (crasher mutant and ap3d1 knockout) causes reduced expression of melanogenesis genes dct and tyrp1b (but not tyr), and autophagy pathway genes are upregulated; treatment with autophagy inhibitor bafilomycin A1 significantly decreases melanophore number in ap3d1 mutants, indicating ap3d1 promotes melanophore survival by limiting excessive autophagy.","method":"Zebrafish genetic model (ENU mutant and CRISPR knockout), RT-qPCR, GAGE pathway analysis, pharmacological inhibition (bafilomycin A1), melanophore counting","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ortholog loss-of-function with gene expression and pharmacological rescue, single lab","pmids":["35816398"],"is_preprint":false},{"year":2026,"finding":"AP3D1/AP-3 is required for RPS6KA3/RSK2-phosphorylation-dependent trafficking of DRAM2 to the late endosomal-lysosomal pathway; phosphorylation of DRAM2 at Ser263 enables its binding to AP3D1, and the non-phosphorylatable DRAM2(S263A) mutant fails to bind AP3D1, exhibits defective lysosomal trafficking, and is instead redirected toward the plasma membrane where it enhances exosome secretion.","method":"Co-immunoprecipitation, phosphorylation mapping (Ser263 mutagenesis), lysosomal trafficking assay, exosome secretion assay, in vitro and in vivo melanoma models","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-specific mutagenesis (S263A) with loss of AP3D1 binding by co-IP plus functional trafficking and secretion readouts, multiple orthogonal methods","pmids":["42059423"],"is_preprint":false},{"year":2018,"finding":"Bovine AP3D1 (boAP3D1) interacts in vitro with the N-terminal domain of BLV envelope glycoprotein gp51; key amino acids on AP3D1 (Lys925, Asp807, Asp695, Arg800) and gp51 were identified as probable interaction residues, and recombinant N-terminal gp51 binding to MDBK cells was sensitive to trypsin and chymotrypsin treatment.","method":"In vitro binding assay with recombinant peptides, homology modeling and docking (in silico), cell-based binding assay with protease sensitivity","journal":"PloS one","confidence":"Low","confidence_rationale":"Tier 3 / Weak — in vitro binding assay and in silico modeling without biochemical validation of the specific AP3D1 residues; ortholog (bovine) with single lab","pmids":["29928016"],"is_preprint":false}],"current_model":"AP3D1 encodes the δ subunit of the AP-3 adaptor protein complex, which is essential for both ubiquitous and neuronal AP-3 complex assembly and is required for vesicle-mediated lysosomal/late endosomal trafficking of specific cargo—including palmitoylated IFNGR1, DRAM2 (in a phosphorylation-dependent manner), and TGFβ2—to regulate lysosomal degradation, autophagic flux, and exosomal secretion; loss of AP3D1 disrupts lysosome-related organelle biogenesis (causing Hermansky-Pudlak syndrome type 10 with albinism, immunodeficiency, platelet dysfunction, and neurological defects), impairs neurotransmitter vesicle turnover in neurons, and alters retinal progenitor differentiation."},"narrative":{"mechanistic_narrative":"AP3D1 encodes the δ subunit of the AP-3 adaptor protein complex and is essential for assembly and stability of both the ubiquitous and neuronal forms of AP-3, which direct vesicle-mediated trafficking of cargo to late endosomal and lysosomal compartments [PMID:26744459]. Through its δ subunit, AP3D1 selects specific cargo for lysosomal delivery: it binds S-palmitoylated IFNGR1 (Cys122) to route the receptor for lysosomal degradation [PMID:33627378], and it captures DRAM2 in a phosphorylation-dependent manner, requiring RSK2-mediated phosphorylation at Ser263, such that the non-phosphorylatable DRAM2(S263A) loses AP3D1 binding and is instead diverted to the plasma membrane to enhance exosome secretion [PMID:42059423]. AP3D1 also participates in TGFβ2 secretion via an AP-3-dependent late endosomal/exosomal route [PMID:34166600] and governs the endolysosomal trafficking and lysosomal localization of cargo such as RNF13 [PMID:34831286]. Consistent with its role in lysosome-related organelle biogenesis, loss-of-function mutations in AP3D1 destabilize the complex and cause a Hermansky-Pudlak-type disorder featuring immunodeficiency with defective T-cell degranulation [PMID:26744459] and abnormal platelet dense granule storage [PMID:30472485]. In the nervous system, AP3D1 loss perturbs neurotransmitter vesicle turnover and synaptic transmission and is required for proper retinal progenitor differentiation [PMID:19032734, PMID:19631730].","teleology":[{"year":2009,"claim":"Establishing the in vivo consequence of Ap3d1 loss showed that the δ subunit is required for vesicle transport supporting neurotransmitter turnover and for retinal neuron differentiation, linking AP-3 to neuronal phenotypes.","evidence":"Genomic mapping of the mocha deletion with patch-clamp electrophysiology and retinal immunohistochemistry in Ap3d1-null mice","pmids":["19032734","19631730"],"confidence":"Medium","gaps":["Specific synaptic vesicle cargo mistrafficked is not identified","Molecular basis of amacrine cell competence defect unknown"]},{"year":2009,"claim":"A genetic suppressor study demonstrated that restoring Ap3d1 expression above a functional threshold via altered pre-mRNA splicing rescues the mutant phenotype, defining Ap3d1 dosage sensitivity.","evidence":"Genetic epistasis with the Nxf1(CAST) allele and quantitative RT-PCR of splice isoforms in mocha mice","pmids":["19436707"],"confidence":"Medium","gaps":["Mechanism by which Nxf1 modulates Ap3d1 splicing not resolved","Threshold quantification specific to one mutant allele"]},{"year":2016,"claim":"Patient genetics established AP3D1 as a disease gene whose loss destabilizes the entire AP-3 complex, with reconstitution rescuing the T-cell degranulation defect, proving AP3D1 is essential for complex assembly and immune lysosome-related organelle function.","evidence":"Whole exome sequencing, retroviral reconstitution with functional degranulation rescue in patient T cells","pmids":["26744459"],"confidence":"High","gaps":["Full spectrum of mistrafficked immune cargo not enumerated","Neurological component of the syndrome not mechanistically dissected"]},{"year":2018,"claim":"An independent loss-of-function family confirmed AP3D1 is required for lysosome-related organelle biogenesis by demonstrating an abnormal platelet dense granule storage pathway.","evidence":"Whole exome sequencing and platelet storage pathway analysis","pmids":["30472485"],"confidence":"Medium","gaps":["Cargo defects underlying granule deficiency not identified","Single family"]},{"year":2018,"claim":"An in vitro and in silico study raised AP3D1 as a candidate binding partner for BLV envelope gp51, but without biochemical validation of the implicated residues.","evidence":"Recombinant peptide binding assay, homology modeling/docking, and protease-sensitivity cell binding with bovine AP3D1","pmids":["29928016"],"confidence":"Low","gaps":["Predicted interaction residues not biochemically validated","Functional relevance to viral entry untested","Bovine ortholog only"]},{"year":2021,"claim":"Identification of palmitoylated IFNGR1 as an AP3D1 cargo revealed how AP-3 controls receptor surface levels and immune signaling, and showed optineurin antagonizes this sorting.","evidence":"Reciprocal co-IP, palmitoylation mapping (Cys122), lysosomal sorting and rescue assays with optineurin knockout","pmids":["33627378"],"confidence":"High","gaps":["Structural basis of palmitoyl-cargo recognition by the δ subunit unknown","Generality across other palmitoylated receptors untested"]},{"year":2021,"claim":"AP3D1 was shown to scaffold a secretory route, forming a complex with FAM13A and TGFβ2 to direct TGFβ2 to late endosomes for exosomal secretion, expanding AP-3 function beyond degradation.","evidence":"Co-immunoprecipitation of the ternary complex and functional secretion assay","pmids":["34166600"],"confidence":"Medium","gaps":["Direct vs indirect contacts within the ternary complex not resolved","Single lab"]},{"year":2021,"claim":"Knockdown placed AP3D1 upstream of RNF13 endolysosomal trafficking, reinforcing its broad role in cargo delivery to lysosomes and endosomal morphology.","evidence":"siRNA knockdown with LAMP1 co-localization microscopy and endosomal vesicle size measurement","pmids":["34831286"],"confidence":"Medium","gaps":["Direct AP3D1-RNF13 binding not demonstrated","Single lab"]},{"year":2022,"claim":"Zebrafish ortholog loss linked ap3d1 to melanophore survival by limiting excessive autophagy and supporting melanogenesis gene expression, connecting AP-3 to pigment cell biology.","evidence":"ENU mutant and CRISPR knockout zebrafish, RT-qPCR, pathway analysis, and bafilomycin A1 rescue with melanophore counting","pmids":["35816398"],"confidence":"Medium","gaps":["Cargo mediating autophagy restraint not identified","Mammalian relevance of the autophagy link not established here"]},{"year":2026,"claim":"Demonstrating phosphorylation-gated cargo selection, RSK2 phosphorylation of DRAM2 at Ser263 was shown to license AP3D1 binding and lysosomal trafficking, with loss of phosphorylation rerouting cargo to plasma-membrane-driven exosome secretion.","evidence":"Co-IP with S263A mutagenesis, lysosomal trafficking and exosome secretion assays in melanoma models","pmids":["42059423"],"confidence":"High","gaps":["Whether δ subunit directly reads the phosphosite or via another AP-3 surface unclear","Generality of phospho-dependent cargo sorting by AP-3 unknown"]},{"year":null,"claim":"How AP3D1 discriminates among its diverse cargo (palmitoylated, phosphorylated, and secretory) and the structural basis of recognition by the δ subunit remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of δ-subunit cargo recognition","Determinants routing cargo to degradation vs exosomal secretion not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,9]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[2,9,4]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[3,4,9]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[2,4,9]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,5]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,2,9]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[2,4,9]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,1]}],"complexes":["AP-3 adaptor complex"],"partners":["IFNGR1","OPTN","FAM13A","TGFB2","DRAM2","RNF13"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O14617","full_name":"AP-3 complex subunit delta-1","aliases":["AP-3 complex subunit delta","Adaptor-related protein complex 3 subunit delta-1","Delta-adaptin"],"length_aa":1153,"mass_kda":130.2,"function":"Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. Involved in process of CD8+ T-cell and NK cell degranulation (PubMed:26744459). In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals (By similarity)","subcellular_location":"Cytoplasm; Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/O14617/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/AP3D1","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"COMMD2","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/search/AP3D1","total_profiled":1310},"omim":[{"mim_id":"617050","title":"HERMANSKY-PUDLAK SYNDROME 10; HPS10","url":"https://www.omim.org/entry/617050"},{"mim_id":"613304","title":"AlkB HOMOLOG 6; ALKBH6","url":"https://www.omim.org/entry/613304"},{"mim_id":"610366","title":"ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1","url":"https://www.omim.org/entry/610366"},{"mim_id":"607246","title":"ADAPTOR-RELATED PROTEIN COMPLEX 3, DELTA-1 SUBUNIT; AP3D1","url":"https://www.omim.org/entry/607246"},{"mim_id":"607244","title":"ADAPTOR-RELATED PROTEIN COMPLEX 4, EPSILON-1 SUBUNIT; AP4E1","url":"https://www.omim.org/entry/607244"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/AP3D1"},"hgnc":{"alias_symbol":["ADTD"],"prev_symbol":[]},"alphafold":{"accession":"O14617","domains":[{"cath_id":"-","chopping":"2-102","consensus_level":"medium","plddt":85.8782,"start":2,"end":102},{"cath_id":"1.25.10.10","chopping":"104-214","consensus_level":"medium","plddt":94.073,"start":104,"end":214},{"cath_id":"-","chopping":"217-295","consensus_level":"medium","plddt":86.3901,"start":217,"end":295},{"cath_id":"2.60.40.1230","chopping":"924-1043","consensus_level":"high","plddt":91.238,"start":924,"end":1043},{"cath_id":"3.30.310.10","chopping":"1048-1152","consensus_level":"high","plddt":89.9832,"start":1048,"end":1152},{"cath_id":"1.25.40","chopping":"420-600","consensus_level":"medium","plddt":88.7996,"start":420,"end":600}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14617","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14617-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14617-F1-predicted_aligned_error_v6.png","plddt_mean":76.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=AP3D1","jax_strain_url":"https://www.jax.org/strain/search?query=AP3D1"},"sequence":{"accession":"O14617","fasta_url":"https://rest.uniprot.org/uniprotkb/O14617.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14617/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14617"}},"corpus_meta":[{"pmid":"26744459","id":"PMC_26744459","title":"Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/26744459","citation_count":129,"is_preprint":false},{"pmid":"33627378","id":"PMC_33627378","title":"Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation.","date":"2021","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/33627378","citation_count":112,"is_preprint":false},{"pmid":"19291304","id":"PMC_19291304","title":"Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes.","date":"2009","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19291304","citation_count":62,"is_preprint":false},{"pmid":"27889060","id":"PMC_27889060","title":"Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy.","date":"2016","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27889060","citation_count":56,"is_preprint":false},{"pmid":"24634799","id":"PMC_24634799","title":"Identification and validation of quantitative PCR reference genes suitable for normalizing expression in normal and dystrophic cell culture models of myogenesis.","date":"2014","source":"PLoS currents","url":"https://pubmed.ncbi.nlm.nih.gov/24634799","citation_count":48,"is_preprint":false},{"pmid":"24916648","id":"PMC_24916648","title":"A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/24916648","citation_count":45,"is_preprint":false},{"pmid":"30472485","id":"PMC_30472485","title":"Biallelic mutations in AP3D1 cause Hermansky-Pudlak syndrome type 10 associated with immunodeficiency and seizure disorder.","date":"2018","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30472485","citation_count":29,"is_preprint":false},{"pmid":"32090267","id":"PMC_32090267","title":"Transcriptional analysis of arogenate dehydratase genes identifies a link between phenylalanine biosynthesis and lignin biosynthesis.","date":"2020","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/32090267","citation_count":19,"is_preprint":false},{"pmid":"29928016","id":"PMC_29928016","title":"In silico and in vitro analysis of boAP3d1 protein interaction with bovine leukaemia virus gp51.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29928016","citation_count":14,"is_preprint":false},{"pmid":"35905627","id":"PMC_35905627","title":"Triphenyltin exposure induced abnormal morphological colouration in adult male guppies (Poecilia reticulata).","date":"2022","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/35905627","citation_count":13,"is_preprint":false},{"pmid":"34762149","id":"PMC_34762149","title":"Evidence of bovine leukemia virus circulating in sheep and buffaloes in Colombia: insights into multispecies infection.","date":"2021","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/34762149","citation_count":13,"is_preprint":false},{"pmid":"34188129","id":"PMC_34188129","title":"Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34188129","citation_count":12,"is_preprint":false},{"pmid":"36171493","id":"PMC_36171493","title":"Epithelioid fibrous histiocytoma: three diagnostically challenging cases with novel ALK gene fusions, unusual storiform growth pattern, and a prominent spindled morphology.","date":"2022","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36171493","citation_count":12,"is_preprint":false},{"pmid":"19436707","id":"PMC_19436707","title":"Multipotent genetic suppression of retrotransposon-induced mutations by Nxf1 through fine-tuning of alternative splicing.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19436707","citation_count":11,"is_preprint":false},{"pmid":"34440217","id":"PMC_34440217","title":"Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues.","date":"2021","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/34440217","citation_count":10,"is_preprint":false},{"pmid":"34166600","id":"PMC_34166600","title":"Connecting COPD GWAS Genes: FAM13A Controls TGFβ2 Secretion by Modulating AP-3 Transport.","date":"2021","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34166600","citation_count":9,"is_preprint":false},{"pmid":"17125464","id":"PMC_17125464","title":"Downregulation of genes encoding for subunits of adaptor complex-3 in cervical carcinomas.","date":"2006","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/17125464","citation_count":9,"is_preprint":false},{"pmid":"34874227","id":"PMC_34874227","title":"Long noncoding RNA SNHG8 accelerates acute gouty arthritis development by upregulating AP3D1 in mice.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34874227","citation_count":8,"is_preprint":false},{"pmid":"30847849","id":"PMC_30847849","title":"Identification of reference genes for quantitative PCR during C3H10T1/2 chondrogenic differentiation.","date":"2019","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30847849","citation_count":8,"is_preprint":false},{"pmid":"37977355","id":"PMC_37977355","title":"Oncolytic virus Ad-TD-nsIL-12 inhibits glioma growth and reprograms the tumor immune microenvironment.","date":"2023","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37977355","citation_count":8,"is_preprint":false},{"pmid":"34831286","id":"PMC_34831286","title":"RNF13 Dileucine Motif Variants L311S and L312P Interfere with Endosomal Localization and AP-3 Complex Association.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34831286","citation_count":8,"is_preprint":false},{"pmid":"19631730","id":"PMC_19631730","title":"Altered retinal cell differentiation in the AP-3 delta mutant (Mocha) mouse.","date":"2009","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19631730","citation_count":8,"is_preprint":false},{"pmid":"38644452","id":"PMC_38644452","title":"Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants.","date":"2024","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/38644452","citation_count":7,"is_preprint":false},{"pmid":"40217412","id":"PMC_40217412","title":"SPOUT1 variants associated with autosomal-recessive developmental and epileptic encephalopathy.","date":"2024","source":"Acta epileptologica","url":"https://pubmed.ncbi.nlm.nih.gov/40217412","citation_count":6,"is_preprint":false},{"pmid":"36445457","id":"PMC_36445457","title":"A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation.","date":"2022","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36445457","citation_count":5,"is_preprint":false},{"pmid":"35816398","id":"PMC_35816398","title":"AP-3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio).","date":"2022","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/35816398","citation_count":4,"is_preprint":false},{"pmid":"38940181","id":"PMC_38940181","title":"Adaptive digital tissue deconvolution.","date":"2024","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/38940181","citation_count":3,"is_preprint":false},{"pmid":"36430862","id":"PMC_36430862","title":"Diagnosing Czech Patients with Inherited Platelet Disorders.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36430862","citation_count":3,"is_preprint":false},{"pmid":"19032734","id":"PMC_19032734","title":"Mapping of the spontaneous deletion in the Ap3d1 gene of mocha mice: fast and reliable genotyping.","date":"2008","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/19032734","citation_count":1,"is_preprint":false},{"pmid":"40191489","id":"PMC_40191489","title":"Genetic Markers of Spina Bifida: Enrichment of Pathogenic Variants and Variants of Uncertain Significance.","date":"2025","source":"Journal of Indian Association of Pediatric Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/40191489","citation_count":1,"is_preprint":false},{"pmid":"41025021","id":"PMC_41025021","title":"Hermansky-Pudlak syndrome-rare type 10 with AP3D1 mutation.","date":"2025","source":"Oxford medical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/41025021","citation_count":0,"is_preprint":false},{"pmid":"40537884","id":"PMC_40537884","title":"Unveiling Biomarkers and Therapeutic Targets in Systemic Sclerosis and Lupus Erythematosus Through Transcriptomic Profiling.","date":"2025","source":"International journal of rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/40537884","citation_count":0,"is_preprint":false},{"pmid":"40634400","id":"PMC_40634400","title":"Reference genes validation in tear fluid for RNA analysis in ocular surface disease.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40634400","citation_count":0,"is_preprint":false},{"pmid":"42059423","id":"PMC_42059423","title":"RPS6KA3/RSK2-mediated phosphorylation of DRAM2 promotes lysosomal targeting and autophagic flux in melanoma.","date":"2026","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/42059423","citation_count":0,"is_preprint":false},{"pmid":"41824434","id":"PMC_41824434","title":"Best reference genes for unbiased normalized transcript expression in normal and dystrophic human cell models of myogenesis.","date":"2026","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41824434","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20594,"output_tokens":2890,"usd":0.052566,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10189,"output_tokens":3437,"usd":0.068435,"stage2_stop_reason":"end_turn"},"total_usd":0.121001,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"AP3D1 encodes the AP3δ subunit essential for both the ubiquitous and neuronal forms of the AP-3 complex; homozygous loss-of-function mutation in AP3D1 destabilizes the entire AP-3 complex, and retroviral reconstitution with wild-type AP3D1 restores AP-3 complex formation and rescues the T-cell degranulation defect in patient cells.\",\n      \"method\": \"Patient genetics (whole exome sequencing), retroviral reconstitution assay, functional degranulation assay in T cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — retroviral reconstitution with functional rescue (degranulation assay) plus patient genetics; replicated by independent clinical report (PMID:30472485)\",\n      \"pmids\": [\"26744459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Homozygous frameshift mutation in AP3D1 (c.1978delG, p.Ala660Argfs*54) causes loss of AP-3 complex function, leading to abnormal platelet storage pathway, confirming AP3D1/AP3δ is required for lysosome-related organelle biogenesis including platelet dense granules.\",\n      \"method\": \"Whole exome sequencing, platelet storage pathway analysis\",\n      \"journal\": \"European journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — independent replication of AP3D1 loss-of-function with functional platelet assay, single lab\",\n      \"pmids\": [\"30472485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AP3D1 binds palmitoylated IFNGR1 (S-palmitoylated on Cys122) and sorts it to the lysosome for degradation; optineurin interacts with AP3D1 to prevent this palmitoylation-dependent lysosomal sorting, thereby maintaining IFNGR1 surface expression and IFNγ/MHC-I signaling.\",\n      \"method\": \"Co-immunoprecipitation, palmitoylation assay, lysosomal trafficking assay, genetic loss-of-function (optineurin KO), rescue experiments\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, palmitoylation mapping (Cys122), lysosomal sorting assay, and in vivo rescue across multiple orthogonal methods in one study\",\n      \"pmids\": [\"33627378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AP3D1 forms a cellular protein complex with FAM13A and TGFβ2; this complex mediates secretion of TGFβ2 through an AP-3-dependent pathway involving delivery to late endosomal compartments for exosomal secretion, with FAM13A acting as a negative regulator targeting a late stage of coat-cargo dissociation.\",\n      \"method\": \"Co-immunoprecipitation, functional secretion assay, protein-protein interaction network validation\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP demonstrating ternary complex plus functional secretion assay, single lab\",\n      \"pmids\": [\"34166600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Knockdown of AP3D1 (AP-3 complex subunit) alters the lysosomal localization of wild-type RNF13 and causes abnormal enlargement of endosomal vesicles, placing AP3D1 upstream of RNF13 endolysosomal trafficking.\",\n      \"method\": \"siRNA knockdown of AP3D1, fluorescence microscopy co-localization with LAMP1, endosomal vesicle size measurement\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function knockdown with defined cellular phenotype (endosomal size, lysosomal mislocalization), single lab, two orthogonal readouts\",\n      \"pmids\": [\"34831286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss of Ap3d1 in mocha mice (10,639 bp deletion covering exons 2–6) results in deficiency in vesicle transport and storage, affecting neurotransmitter vesicle turnover; Ap3d1-null hippocampal neurons show higher input resistance and faster, stronger depression of glutamatergic autaptic EPSCs compared to controls.\",\n      \"method\": \"Genomic sequencing to map deletion, patch-clamp electrophysiology on cultured hippocampal neurons from Ap3d1-/- mice\",\n      \"journal\": \"BMC research notes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined genetic null model with functional electrophysiological readout in neurons, single lab\",\n      \"pmids\": [\"19032734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ap3d1 loss in mocha mice causes complete absence of cholinergic amacrine cells and reduction of parvalbumin-expressing and other amacrine cell subtypes in the retina without affecting overall retinal layering, cell number, proliferation, or apoptosis, indicating AP3D1 regulates retinal progenitor cell competence and differentiation.\",\n      \"method\": \"Immunohistochemistry and morphological analysis of Ap3d1-/- (mocha) mouse retina at birth\",\n      \"journal\": \"International journal of developmental neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined genetic null with specific cellular phenotype (amacrine cell subtypes), single lab\",\n      \"pmids\": [\"19631730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The Nxf1(CAST) allele suppresses the Ap3d1(mh2J) IAP retrovirus insertion mutation by approximately 2-fold increase in correctly-spliced Ap3d1 mRNA and decrease in mutant-specific alternatively-processed RNA, demonstrating that Ap3d1 expression can be rescued at a functional threshold through modulation of pre-mRNA splicing.\",\n      \"method\": \"Genetic epistasis (suppressor screen with Nxf1 allele), quantitative RT-PCR for splice isoforms in mocha mice\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic suppressor with molecular splice quantification, single lab but orthogonal genetic and molecular methods\",\n      \"pmids\": [\"19436707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss of ap3d1 in zebrafish (crasher mutant and ap3d1 knockout) causes reduced expression of melanogenesis genes dct and tyrp1b (but not tyr), and autophagy pathway genes are upregulated; treatment with autophagy inhibitor bafilomycin A1 significantly decreases melanophore number in ap3d1 mutants, indicating ap3d1 promotes melanophore survival by limiting excessive autophagy.\",\n      \"method\": \"Zebrafish genetic model (ENU mutant and CRISPR knockout), RT-qPCR, GAGE pathway analysis, pharmacological inhibition (bafilomycin A1), melanophore counting\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ortholog loss-of-function with gene expression and pharmacological rescue, single lab\",\n      \"pmids\": [\"35816398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"AP3D1/AP-3 is required for RPS6KA3/RSK2-phosphorylation-dependent trafficking of DRAM2 to the late endosomal-lysosomal pathway; phosphorylation of DRAM2 at Ser263 enables its binding to AP3D1, and the non-phosphorylatable DRAM2(S263A) mutant fails to bind AP3D1, exhibits defective lysosomal trafficking, and is instead redirected toward the plasma membrane where it enhances exosome secretion.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation mapping (Ser263 mutagenesis), lysosomal trafficking assay, exosome secretion assay, in vitro and in vivo melanoma models\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-specific mutagenesis (S263A) with loss of AP3D1 binding by co-IP plus functional trafficking and secretion readouts, multiple orthogonal methods\",\n      \"pmids\": [\"42059423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bovine AP3D1 (boAP3D1) interacts in vitro with the N-terminal domain of BLV envelope glycoprotein gp51; key amino acids on AP3D1 (Lys925, Asp807, Asp695, Arg800) and gp51 were identified as probable interaction residues, and recombinant N-terminal gp51 binding to MDBK cells was sensitive to trypsin and chymotrypsin treatment.\",\n      \"method\": \"In vitro binding assay with recombinant peptides, homology modeling and docking (in silico), cell-based binding assay with protease sensitivity\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — in vitro binding assay and in silico modeling without biochemical validation of the specific AP3D1 residues; ortholog (bovine) with single lab\",\n      \"pmids\": [\"29928016\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"AP3D1 encodes the δ subunit of the AP-3 adaptor protein complex, which is essential for both ubiquitous and neuronal AP-3 complex assembly and is required for vesicle-mediated lysosomal/late endosomal trafficking of specific cargo—including palmitoylated IFNGR1, DRAM2 (in a phosphorylation-dependent manner), and TGFβ2—to regulate lysosomal degradation, autophagic flux, and exosomal secretion; loss of AP3D1 disrupts lysosome-related organelle biogenesis (causing Hermansky-Pudlak syndrome type 10 with albinism, immunodeficiency, platelet dysfunction, and neurological defects), impairs neurotransmitter vesicle turnover in neurons, and alters retinal progenitor differentiation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"AP3D1 encodes the δ subunit of the AP-3 adaptor protein complex and is essential for assembly and stability of both the ubiquitous and neuronal forms of AP-3, which direct vesicle-mediated trafficking of cargo to late endosomal and lysosomal compartments [#0]. Through its δ subunit, AP3D1 selects specific cargo for lysosomal delivery: it binds S-palmitoylated IFNGR1 (Cys122) to route the receptor for lysosomal degradation [#2], and it captures DRAM2 in a phosphorylation-dependent manner, requiring RSK2-mediated phosphorylation at Ser263, such that the non-phosphorylatable DRAM2(S263A) loses AP3D1 binding and is instead diverted to the plasma membrane to enhance exosome secretion [#9]. AP3D1 also participates in TGFβ2 secretion via an AP-3-dependent late endosomal/exosomal route [#3] and governs the endolysosomal trafficking and lysosomal localization of cargo such as RNF13 [#4]. Consistent with its role in lysosome-related organelle biogenesis, loss-of-function mutations in AP3D1 destabilize the complex and cause a Hermansky-Pudlak-type disorder featuring immunodeficiency with defective T-cell degranulation [#0] and abnormal platelet dense granule storage [#1]. In the nervous system, AP3D1 loss perturbs neurotransmitter vesicle turnover and synaptic transmission and is required for proper retinal progenitor differentiation [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Establishing the in vivo consequence of Ap3d1 loss showed that the δ subunit is required for vesicle transport supporting neurotransmitter turnover and for retinal neuron differentiation, linking AP-3 to neuronal phenotypes.\",\n      \"evidence\": \"Genomic mapping of the mocha deletion with patch-clamp electrophysiology and retinal immunohistochemistry in Ap3d1-null mice\",\n      \"pmids\": [\"19032734\", \"19631730\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific synaptic vesicle cargo mistrafficked is not identified\", \"Molecular basis of amacrine cell competence defect unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A genetic suppressor study demonstrated that restoring Ap3d1 expression above a functional threshold via altered pre-mRNA splicing rescues the mutant phenotype, defining Ap3d1 dosage sensitivity.\",\n      \"evidence\": \"Genetic epistasis with the Nxf1(CAST) allele and quantitative RT-PCR of splice isoforms in mocha mice\",\n      \"pmids\": [\"19436707\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which Nxf1 modulates Ap3d1 splicing not resolved\", \"Threshold quantification specific to one mutant allele\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Patient genetics established AP3D1 as a disease gene whose loss destabilizes the entire AP-3 complex, with reconstitution rescuing the T-cell degranulation defect, proving AP3D1 is essential for complex assembly and immune lysosome-related organelle function.\",\n      \"evidence\": \"Whole exome sequencing, retroviral reconstitution with functional degranulation rescue in patient T cells\",\n      \"pmids\": [\"26744459\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full spectrum of mistrafficked immune cargo not enumerated\", \"Neurological component of the syndrome not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"An independent loss-of-function family confirmed AP3D1 is required for lysosome-related organelle biogenesis by demonstrating an abnormal platelet dense granule storage pathway.\",\n      \"evidence\": \"Whole exome sequencing and platelet storage pathway analysis\",\n      \"pmids\": [\"30472485\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cargo defects underlying granule deficiency not identified\", \"Single family\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"An in vitro and in silico study raised AP3D1 as a candidate binding partner for BLV envelope gp51, but without biochemical validation of the implicated residues.\",\n      \"evidence\": \"Recombinant peptide binding assay, homology modeling/docking, and protease-sensitivity cell binding with bovine AP3D1\",\n      \"pmids\": [\"29928016\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Predicted interaction residues not biochemically validated\", \"Functional relevance to viral entry untested\", \"Bovine ortholog only\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of palmitoylated IFNGR1 as an AP3D1 cargo revealed how AP-3 controls receptor surface levels and immune signaling, and showed optineurin antagonizes this sorting.\",\n      \"evidence\": \"Reciprocal co-IP, palmitoylation mapping (Cys122), lysosomal sorting and rescue assays with optineurin knockout\",\n      \"pmids\": [\"33627378\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of palmitoyl-cargo recognition by the δ subunit unknown\", \"Generality across other palmitoylated receptors untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"AP3D1 was shown to scaffold a secretory route, forming a complex with FAM13A and TGFβ2 to direct TGFβ2 to late endosomes for exosomal secretion, expanding AP-3 function beyond degradation.\",\n      \"evidence\": \"Co-immunoprecipitation of the ternary complex and functional secretion assay\",\n      \"pmids\": [\"34166600\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect contacts within the ternary complex not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Knockdown placed AP3D1 upstream of RNF13 endolysosomal trafficking, reinforcing its broad role in cargo delivery to lysosomes and endosomal morphology.\",\n      \"evidence\": \"siRNA knockdown with LAMP1 co-localization microscopy and endosomal vesicle size measurement\",\n      \"pmids\": [\"34831286\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct AP3D1-RNF13 binding not demonstrated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Zebrafish ortholog loss linked ap3d1 to melanophore survival by limiting excessive autophagy and supporting melanogenesis gene expression, connecting AP-3 to pigment cell biology.\",\n      \"evidence\": \"ENU mutant and CRISPR knockout zebrafish, RT-qPCR, pathway analysis, and bafilomycin A1 rescue with melanophore counting\",\n      \"pmids\": [\"35816398\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cargo mediating autophagy restraint not identified\", \"Mammalian relevance of the autophagy link not established here\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Demonstrating phosphorylation-gated cargo selection, RSK2 phosphorylation of DRAM2 at Ser263 was shown to license AP3D1 binding and lysosomal trafficking, with loss of phosphorylation rerouting cargo to plasma-membrane-driven exosome secretion.\",\n      \"evidence\": \"Co-IP with S263A mutagenesis, lysosomal trafficking and exosome secretion assays in melanoma models\",\n      \"pmids\": [\"42059423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether δ subunit directly reads the phosphosite or via another AP-3 surface unclear\", \"Generality of phospho-dependent cargo sorting by AP-3 unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How AP3D1 discriminates among its diverse cargo (palmitoylated, phosphorylated, and secretory) and the structural basis of recognition by the δ subunit remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of δ-subunit cargo recognition\", \"Determinants routing cargo to degradation vs exosomal secretion not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 9]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [2, 9, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3, 4, 9]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2, 4, 9]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 2, 9]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [2, 4, 9]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\"AP-3 adaptor complex\"],\n    \"partners\": [\"IFNGR1\", \"OPTN\", \"FAM13A\", \"TGFB2\", \"DRAM2\", \"RNF13\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}